HomeTRDA • NASDAQ
Entrada Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 37.40M | -10.63% |
Operating expense | 9.86M | 13.95% |
Net income | 1.13M | 111.85% |
Net profit margin | 3.02 | 113.24% |
Earnings per share | 0.03 | 110.71% |
EBITDA | -4.88M | -186.42% |
Effective tax rate | 253.04% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 420.00M | 19.33% |
Total assets | 526.32M | 12.18% |
Total liabilities | 97.64M | -56.95% |
Total equity | 428.68M | — |
Shares outstanding | 35.63M | — |
Price to book | 0.90 | — |
Return on assets | -2.71% | — |
Return on capital | -3.02% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.13M | 111.85% |
Cash from operations | -31.61M | -687.57% |
Cash from investing | 53.37M | 180.23% |
Cash from financing | 1.40M | 103.19% |
Net change in cash | 23.16M | 47.34% |
Free cash flow | -33.60M | -422.30% |
Previous close
$10.82
Day range
$10.85 - $11.14
Year range
$10.22 - $21.79
Market cap
413.49M USD
Avg Volume
119.26K
P/E ratio
6.55
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
183
